glp 1 2025 How Employers Can Manage GLP-1 Costs in Their Health Plans GLP-1 Pipeline Update: November 2025
Description
3% reported dizziness
It usually has more to do with one of those than the meds suddenly quitting
Competition can eventually place downward pressure on prices, but the process may take years and can depend on patents, litigation, regulatory approvals and manufacturing capacity
When a medication is not stored as directed, it may not perform as expected, and patients may not get the full benefit of their treatment plan
[DOI] [PubMed] [Google Scholar] 150.Cunningham K.M., Read N.W
